Heron Therapeutics
HRTX
#7836
Rank
NZ$0.45 B
Marketcap
$3.01
Share price
0.58%
Change (1 day)
-32.29%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.94

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.04. In 2022 the company made an earnings per share (EPS) of -$3.01 an increase over its 2021 EPS that were of -$3.92.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.94-35.71%
2022-$3.01-23.11%
2021-$3.92-10%
2020-$4.35-0%
2019-$4.351.21%
2018-$4.30-32.7%
2017-$6.39-19.34%
2016-$7.9254.76%
2015-$5.121.73%
2014-$5.03-16.23%
2013-$6.0191.67%
2012-$3.13-31.45%
2011-$4.57-27.06%
2010-$6.27-43.75%
2009-$11.15-57.33%
2008-$26.12-82.92%
2007-$152.9120.61%
2006-$126.78175.76%
2005-$45.98-21.43%
2004-$58.51100%
2003-$29.26-38.24%
2002-$47.37161.54%
2001-$18.11-106.46%
2000$280.202051.55%
1999$13.02839.73%
1998$1.39-105.48%
1997-$25.31-88.16%
1996-$213.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.26-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.24-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.84 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.73-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.87 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA